Brief: ImpediMed Extends Contract For AstraZeneca For Use Of The SOZO Digital Health Platform In Clinical Trial Of Patients With Chronic Kidney Disease
16/11/2022 14:06
Nov 16 (Reuters) - ImpediMed Ltd IPD.AX :
* IMPEDIMED EXTENDS CONTRACT FOR ASTRAZENECA FOR USE OF THE
SOZO
DIGITAL HEALTH PLATFORM IN CLINICAL TRIAL OF PATIENTS WITH
CHRONIC KIDNEY DISEASE
* IMPEDIMED LTD - TRIAL, INVOLVING 210 SOZO DEVICES, HAS
BEEN
EXTENDED FROM 21 MONTHS TO 29 MONTHS
* IMPEDIMED LTD - USE OF SOZO WITHIN TRIAL IS NOW SCHEDULED
TO BE
COMPLETED IN APRIL 2023
Source text for Eikon: ID:nPn6L4tp0a
Further company coverage: IPD.AX